Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.0829 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.03889 | 67 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.04327 | 67 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.95838 | 66 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.98574 | 66 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.31092 | 70 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.07636 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.03538 | 67 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.02103 | 66 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.22193 | 69 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.03093 | 67 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.98328 | 66 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.99359 | 66 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.0304 | 67 |